U.S. Markets closed

Dechra Pharmaceuticals plc (DPH.L)

LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
1,990.00+18.00 (+0.91%)
At close: 4:35PM BST
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue359,000248,000203,000194,000
Cost of Revenue168,000109,00087,00086,000
Gross Profit192,000139,000116,000108,000
Operating Expenses
Research Development----
Selling General and Administrative----
Non Recurring----
Total Operating Expenses326,000215,000177,000168,000
Operating Income or Loss33,00033,00026,00026,000
Income from Continuing Operations
Total Other Income/Expenses Net----
Earnings Before Interest and Taxes33,00033,00026,00026,000
Interest Expense-5,000-2,000-1,000-3,000
Income Before Tax----
Income Tax Expense2,0002,0006,0002,000
Minority Interest----
Net Income From Continuing Ops----
Non-recurring Events
Discontinued Operations---40,000
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income26,00013,00019,00059,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares----